The slip
PARKINSON RECEIPTno. 4771
21 Oct 2026, 01:25 UTCdopamine neurons, braak
predictionKCNG2 in dopamine neurons tracks Braak Lewy-body stage
registered9e5e027bad3ac354
discovery-0.75 p=0.019 n=9
replication-0.12 p=0.767 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery -0.75 p 0.019; held-out -0.12 p 0.767)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATE63e5942c905733b4244874f6…
follows a3c7348a6333…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4771: KCNG2 in dopamine neurons, braak
- power
- full sample -0.45 (p 0.063, n 18), 95% CI -0.76 to +0.03. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.45 (p 0.063, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.47 (p 0.047, n 18). not the mix.
- skeptic
- leave-one-out range -0.59 to -0.38, sign flips 0; without severely affected donors -0.45 (p 0.063, n 18). robust.
- cell type
- strongest in OPCs: -0.61 (p 0.0067, n 18) vs -0.45 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for KCNG2 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up KCNG2 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.68 p 0.016 (needs p < 4.1e-4)